Marine mammals’ adaptations to low oxygen offer new perspective on COVID-19 — ScienceDaily

When Terrie Williams began hearing about the wide range of symptoms experienced by patients with COVID-19, she saw a connection between the various ways the disease is affecting people and the many physiological adaptations that have enabled marine mammals to tolerate low oxygen levels during dives.

Williams, a professor of ecology and evolutionary biology at UC Santa Cruz, has spent decades studying the physiology of marine mammals and their extraordinary ability to perform strenuous activities while holding their breath for long periods under water.

“Diving marine mammals experience a lifetime of rapid physiological transitions between normal oxygenation and hypoxia [low oxygen levels],” Williams said. “They’ve got ways to protect themselves and allow their organs to keep functioning while holding their breath for hours at a time, but there’s a whole suite of biological adaptations that had to happen for them to be able to do that.”

Lacking those adaptations, humans

Read More

Texas Tech head coach Matt Wells tests positive for COVID-19 ahead of game vs. Kansas

Texas Tech announced Thursday that head football coach Matt Wells has tested positive for COVID-19.

The Red Raiders (3-6, 2-6 Big 12) are scheduled to host Kansas for an 11 a.m. kickoff on Saturday in Lubbock.

”Texas Tech received notification earlier this morning that Coach Wells tested positive for COVID-19. At this time, Coach Wells has returned home to self-isolate and will continue his duties remotely leading into Saturday’s game against Kansas,” the school said in a statement.

“He will remain in the Big 12′s testing guidelines in order to confirm the positive test. In the case Wells is unable to lead the Red Raiders on Saturday, defensive coordinator Keith Patterson will serve in the head coach capacity.”

Wells is 7-14 since taking over the Red Raiders, who after a big comeback of their own to beat Baylor on a game-ending field goal in their last home game three weeks

Read More

Covid-19 Is derailing cancer clinical trials. Is new technology required to get them back on track?

Paper made silhouettes with one of them of orange color to stand out from the rest

The coronavirus pandemic has affected every aspect of American healthcare. Some have postponed medical, dental or vision appointments for themselves or family members out of fear of contracting the virus. Many providers have deferred nonessential visits to slow the pandemic’s spread and keep critical staff available to treat patients with Covid-19.

The clinical trial cycle is also experiencing significant disruption. One leading oncology practice publication notes that new cancer diagnoses are down 37% since the pandemic began, and IQVIA data shows that “22 million people postponed cancer screening tests and 80,000 patients delayed or missed diagnoses.” (IQVIA is an investor in Inteliquet, the company I lead as president and COO).

How do we ensure that the right patient can still access the right drug at the right time, at a time when many oncology clinical trials which would provide a much-needed treatment option have been delayed?

A Cancer Diagnosis Has

Read More

Hackers Target Covid-19 Vaccine Distribution ‘Cold Chain’: IBM

A special freezer manufactured by Binder, seen here in Tuttlingen, Germany in November 2020.

Photo: Thomas Kienzle (Getty Images)

Hackers “assumed to be state agents” have been waging a phishing campaign against pharmaceutical firms and other institutions involved in the forthcoming distribution of a vaccine against the novel coronavirus, IBM announced on Thursday.

In a post on Security Intelligence releasing their findings, IBM Security X-Force researchers wrote that “precision targeting of executives and key global organizations hold the potential hallmarks of a nation-state tradecraft,” adding the unknown hackers likely sought to obtain “advanced insight into the purchase and movement of a vaccine that can impact life and the global economy.” The target, according to IBM, appears to be the “cold chain”—a term for the logistics network that allows vaccines and other drugs to be carried from point of manufacture to distribution in temperature-controlled shipping containers. What the attackers hoped to accomplish is unknown, with possible motives ranging from theft of

Read More

What makes certain groups more vulnerable to COVID-19? Researchers look to animals to find clues in proteins involved in infection — ScienceDaily

What makes the elderly and people with underlying conditions more vulnerable to COVID-19? According to a new study led by McGill University researchers, clues can be found in the proteins involved in initiating infection, as the virus binds to host cells of different animals. Greater cellular oxidation with aging and sickness may explain why seniors and people with chronic illness get infected more often and more severely.

Over 60 million people have been infected and around 1.5 million have died from COVID-19. The virus is disrupting economies and food supply chains all over the world. Understanding why some animals get infected and others do not could be the key to unlocking new treatments and therapies. In a study published in Computational and Structural Biotechnology Journal, researchers analyzed available protein sequences of the virus and host cell receptors across different spices to find out why.

“We know that the virus can

Read More

3-D protein modeling suggests why COVID-19 infects some animals, but not others

3D protein modeling suggests why COVID-19 infects some animals, but not others
3D structure model of the receptor-binding domain of SARS-CoV-2 (in blue) interacting with the human ACE2 receptor (in gray). Amino acids important to the interaction, which are present only in COVID-susceptible animal species are highlighted in yellow. Sugars bound to the proteins are shown in pink. Credit: Rodrigues et al. 2020 (CC-BY 2.0)

Some animals are more susceptible to COVID-19 infection than others, and new research suggests this may be due to distinctive structural features of a protein found on the surface of animal cells. João Rodrigues of Stanford University, California, and colleagues present these findings in the open-access journal PLOS Computational Biology.


Previous research suggests that the current pandemic began when the virus that causes COVID-19, SARS-CoV-2, jumped from bats or pangolins to humans. Certain other animals, such as cattle and cats, appear to be susceptible to COVID-19, while others, such as pigs and chickens, are not. One

Read More

Pfizer CEO Is ‘Confident’ In Covid-19 Vaccine Rollout And Looking Beyond The Pandemic


At the 2020 Forbes Healthcare Summit, Albert Bourla is already looking beyond his company’s vaccine success and into a post-pandemic world.


Pfizer CEO Albert Bourla has accomplished in 11 months what usually takes years, with the company’s Covid-19 vaccine ready to hit the market in record time. Bourla told the 2020 Forbes Healthcare Summit he’s “confident” in the upcoming rollout and already looking towards future ways to apply the vaccine’s underlying technology. 

“We knew that the world needs this. We knew that we had to deliver. And we didn’t let any obstacles—and I can assure you there were many in our way—to stop us doing it,” Bourla told moderator Moira Forbes, president and publisher of ForbesWomen. His remarks came one day after Pfizer, along with its partner BioNTech, became the first companies in the world to get authorization for a Covid-19

Read More

The impact of COVID-19 on Multiplex Assay Technology Market 2026 Global Size, Key Companies, Trends, Growth and Regional Forecasts Research

The MarketWatch News Department was not involved in the creation of this content.

Dec 03, 2020 (The Expresswire) —
The Multiplex Assay Technology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

A comprehensive estimate on the Multiplex Assay Technology market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of Multiplex Assay Technology during the forecast period. Price point comparison by region with global average price is also considered in the study.

Get a Sample PDF of report @https://www.marketgrowthreports.com/enquiry/request-sample/16011990

Summary of Multiplex Assay Technology Market:

The global Multiplex Assay Technology market size is expected to gain

Read More

Former Presidents Obama, Clinton and Bush say they’d take COVID-19 vaccine on camera to promote its safety

Former Presidents Barack Obama, George W. Bush and Bill Clinton plan to take a coronavirus vaccine on camera to raise confidence in its safety. 

Mr. Obama said in an interview excerpt on Sirius XM released Wednesday that if the nation’s top infectious disease expert, Dr. Anthony Fauci, told him the vaccine was safe, he would believe him and signaled that he’d take it himself. 

“So, if Anthony Fauci tells me this vaccine is safe, and can vaccinate, immunize you from getting COVID,” he said. “Absolutely, I’m going to take it.” 

“I promise you that when it’s been made for people who are less at risk, I will be taking it,” he said. “I may end up taking it on TV or having it filmed, just so that people know that I trust this science, and what I don’t trust is getting COVID.” 

Two of his living predecessors said they would

Read More

3 former presidents say they’d take COVID-19 vaccine on camera

Former Presidents Barack Obama, George W. Bush and Bill Clinton plan to take a coronavirus vaccine on camera to raise confidence in its safety. 



George W. Bush, Tim Finchem standing in front of a crowd: The Presidents Cup - Round One


© Patrick Smith / Getty Images
The Presidents Cup – Round One

Mr. Obama said in an interview excerpt on Sirius XM released Wednesday that if the nation’s top infectious disease expert, Dr. Anthony Fauci, told him the vaccine was safe, he would believe him and signaled that he’d take it himself. 

“So, if Anthony Fauci tells me this vaccine is safe, and can vaccinate, immunize you from getting COVID,” he said. “Absolutely, I’m going to take it.” 

“I promise you that when it’s been made for people who are less at risk, I will be taking it,” he said. “I may end up taking it on TV or having it filmed, just so that people know that I trust this science, and what I

Read More